Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor

Agonists of the stimulator of interferon genes (STING) play a key role in activating the STING pathway by promoting the production of cytokines. In this study, we investigated the antitumor effects and activation of the systemic immune response of treatment with DMXAA (5,6-dimethylxanthenone-4-aceti...

Full description

Saved in:
Bibliographic Details
Published in:Yonsei medical journal 2022, 63(1), , pp.42-55
Main Authors: Synn, Chun-Bong, Kim, Dong Kwon, Kim, Jae Hwan, Byeon, Youngseon, Kim, Young Seob, Yun, Mi Ran, Lee, Ji Min, Lee, Wongeun, Lee, Eun Ji, Lee, Seul, Lee, You-Won, Lee, Doo Jae, Kim, Hyun-Woo, Kim, Chang Gon, Hong, Min Hee, Park, June Dong, Lim, Sun Min, Pyo, Kyoung-Ho
Format: Article
Language:English
Subjects:
Animals
Immunotherapy
Macrophages
Membrane Proteins - genetics
Memory T Cells
Mice
Original
Skin Neoplasms
의학일반
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Agonists of the stimulator of interferon genes (STING) play a key role in activating the STING pathway by promoting the production of cytokines. In this study, we investigated the antitumor effects and activation of the systemic immune response of treatment with DMXAA (5,6-dimethylxanthenone-4-acetic acid), a STING agonist, in EML4-ALK lung cancer and CT26 colon cancer. The abscopal effects of DMXAA in the treatment of metastatic skin nodules were assessed. EML4-ALK lung cancer and CT26 colon cancer models were used to evaluate these effects after DMXAA treatment. To evaluate the expression of macrophages and T cells, we sacrificed the tumor-bearing mice after DMXAA treatment and obtained the formalin-fixed paraffin-embedded (FFPE) tissue and tumor cells. Immunohistochemistry and flow cytometry were performed to analyze the expression of each FFPE and tumor cell. We observed that highly infiltrating immune cells downstream of the STING pathway had increased levels of chemokines after DMXAA treatment. In addition, the levels of CD80 and CD86 in antigen-presenting cells were significantly increased after STING activation. Furthermore, innate immune activation altered the systemic T cell-mediated immune responses, induced proliferation of macrophages, inhibited tumor growth, and increased numbers of cytotoxic memory T cells. Tumor-specific lymphocytes also increased in number after treatment with DMXAA. The abscopal effect of DMXAA treatment on the skin strongly reduced the spread of EML4-ALK lung cancer and CT26 colon cancer through the STING pathway and induced the presentation of antigens.
ISSN:0513-5796
1976-2437
DOI:10.3349/YMJ.2022.63.1.42